Growth Metrics

Resmed (RMD) Income from Continuing Operations (2016 - 2025)

Resmed's Income from Continuing Operations history spans 17 years, with the latest figure at 392593000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 13.92% year-over-year to 392593000.0; the TTM value through Dec 2025 reached 1485875000.0, up 18.99%, while the annual FY2025 figure was 1400723000.0, 37.2% up from the prior year.
  • Income from Continuing Operations reached 392593000.0 in Q4 2025 per RMD's latest filing, up from 348536000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 392593000.0 in Q4 2025 to a low of 78481000.0 in Q1 2021.
  • Average Income from Continuing Operations over 5 years is 247820700.0, with a median of 227289000.0 recorded in 2022.
  • Peak YoY movement for Income from Continuing Operations: tumbled 148.11% in 2021, then surged 328.1% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 201751000.0 in 2021, then increased by 11.48% to 224914000.0 in 2022, then fell by 7.16% to 208800000.0 in 2023, then surged by 65.05% to 344622000.0 in 2024, then grew by 13.92% to 392593000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMD's Income from Continuing Operations are 392593000.0 (Q4 2025), 348536000.0 (Q3 2025), and 379705000.0 (Q2 2025).